MedPath

Nexus Pharmaceuticals, Inc.

Nexus Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
2003-01-01
Employees
51
Market Cap
-
Website
https://www.nexuspharma.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

FDA:14

Drug Approvals

BACLOFEN

Approval Date
Mar 19, 2024
FDA

Potassium Chloride

Approval Date
Sep 13, 2023
FDA

Sterile Water

Approval Date
Jul 18, 2023
FDA

Potassium Chloride

Approval Date
Jun 13, 2023
FDA

Levetiracetam in Sodium Chloride

Approval Date
Jun 8, 2023
FDA

Succinylcholine Chloride

Approval Date
May 30, 2023
FDA

Isoproterenol Hydrochloride

Approval Date
Mar 31, 2023
FDA

Erythromycin Lactobionate

Approval Date
Mar 9, 2023
FDA

Papaverine Hydrochloride

Approval Date
Jan 31, 2023
FDA

Emerphed

Approval Date
Sep 30, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.